Trial Profile
Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2023
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms DGVTAF
- 26 Apr 2023 Planned End Date changed from 1 Apr 2023 to 1 Apr 2025.
- 26 Apr 2023 Planned primary completion date changed from 1 Apr 2023 to 1 Apr 2024.
- 01 Jun 2021 Status changed from recruiting to active, no longer recruiting.